Position
Creative Planning in Viking Therapeutics, Inc.
Back to the book · All holders of VKTX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$81.2K$35.18 → $32.54
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 30.7K | $1.08M | — | — | — | 0.0% |
| Q1 2026 | 32.7K | $1.06M | $32.54 | −$81.2K | $63K | 0.0% |